This report generates SAS reports of adverse events counts and percentages by treatment arm, sex, and race.
Running this report for the Nicardipine study generates a PDF, and/or rtf file summary of the adverse events experienced by the subjects in the trial grouped by treatment, gender and race. The inclusion of an additional table showing counts of each adverse event by severity level can be specified.
The PDF format also contains hyperlinks in their left pane for ease of navigation to specific reports.
Note: Adverse events must meet or exceed the specified threshold occurrence to be included.
Note: For information about how treatment emergent adverse events (TEAEs) are defined in JMP Clinical, please refer to How does JMP Clinical determine whether an Event Is a Treatment Emergent Adverse Event?.